TY - JOUR
T1 - Mortality among patients treated for aneurysmal subarachnoid hemorrhage in Eastern Denmark 2017-2019
AU - Stauning, Agnes T
AU - Eriksson, Frank
AU - Benndorf, Goetz
AU - Holst, Anders V
AU - Hauerberg, John
AU - Stavngaard, Trine
AU - Poulsgaard, Lars
AU - Rochat, Per
AU - Eskesen, Vagn
AU - Birkeland, Peter
AU - Mathiesen, Tiit
AU - Munch, Tina N
N1 - © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
PY - 2022/9
Y1 - 2022/9
N2 - OBJECTIVE: The aim of the study was to investigate (1) the 30-day, 3-month, and 12-month cumulative mortalities for patients who underwent aneurysm occlusion, and (2) the causes of death, and (3) the potential risk factors for death.METHODS: All patients who underwent surgical clipping or endovascular treatment of a ruptured aneurysm at Copenhagen University Hospital, during the period of January 1, 2017-December 31, 2019, were included and followed up for 12 months. Data regarding vital status, causes of death, comorbidities, treatment, and clinical presentations on admission was collected. The absolute mortality risk was estimated as a function of time with a 95% confidence interval. The associations between potential risk factors and death were estimated as odds ratios with 95% confidence intervals using logistic regression models.RESULTS: A total of 317 patients were included. The overall cumulative mortalities after 30 days, 3 months, and 12 months were 10.7%, 12.9%, and 16.1%, respectively. The most common cause of death was severe primary hemorrhage (52.9%), followed by infections (15.7%) and rebleeding (11.8%). WFNS score > 3 and Fisher score > 3 on admission, preprocedural hydrocephalus, and preprocedural rebleeding were found significantly associated with higher risk of death.CONCLUSIONS: Considerable mortality was seen. Possible preventable causes accounted for approximately 22% of the deaths. The occurrence of both pre- and postprocedural rebleeding's indicates an opportunity of further improvement of the mortality by (1) further reduction of time from aSAH to aneurysm occlusion and (2) continuous efforts in improving methods of aneurysm occlusion.
AB - OBJECTIVE: The aim of the study was to investigate (1) the 30-day, 3-month, and 12-month cumulative mortalities for patients who underwent aneurysm occlusion, and (2) the causes of death, and (3) the potential risk factors for death.METHODS: All patients who underwent surgical clipping or endovascular treatment of a ruptured aneurysm at Copenhagen University Hospital, during the period of January 1, 2017-December 31, 2019, were included and followed up for 12 months. Data regarding vital status, causes of death, comorbidities, treatment, and clinical presentations on admission was collected. The absolute mortality risk was estimated as a function of time with a 95% confidence interval. The associations between potential risk factors and death were estimated as odds ratios with 95% confidence intervals using logistic regression models.RESULTS: A total of 317 patients were included. The overall cumulative mortalities after 30 days, 3 months, and 12 months were 10.7%, 12.9%, and 16.1%, respectively. The most common cause of death was severe primary hemorrhage (52.9%), followed by infections (15.7%) and rebleeding (11.8%). WFNS score > 3 and Fisher score > 3 on admission, preprocedural hydrocephalus, and preprocedural rebleeding were found significantly associated with higher risk of death.CONCLUSIONS: Considerable mortality was seen. Possible preventable causes accounted for approximately 22% of the deaths. The occurrence of both pre- and postprocedural rebleeding's indicates an opportunity of further improvement of the mortality by (1) further reduction of time from aSAH to aneurysm occlusion and (2) continuous efforts in improving methods of aneurysm occlusion.
KW - Aneurysm, Ruptured/surgery
KW - Denmark/epidemiology
KW - Endovascular Procedures/adverse effects
KW - Humans
KW - Intracranial Aneurysm/complications
KW - Retrospective Studies
KW - Subarachnoid Hemorrhage/complications
KW - Treatment Outcome
UR - http://www.scopus.com/inward/record.url?scp=85134584291&partnerID=8YFLogxK
U2 - 10.1007/s00701-022-05303-w
DO - 10.1007/s00701-022-05303-w
M3 - Journal article
C2 - 35864221
SN - 0001-6268
VL - 164
SP - 2419
EP - 2430
JO - Acta Neurochirurgica
JF - Acta Neurochirurgica
IS - 9
ER -